ETS-related gene transcription factor ERG (ERG)

ETS-related gene transcription factor ERG (ERG) is a nuclear protein and oncogenic transcription factor of the ETS family, which recognizes purine-rich DNA motifs and regulates key biological processes including embryonic development, hematopoietic stem cell maintenance, angiogenesis, endothelial homeostasis, and platelet function[1][2][4]. ERG functions through direct DNA binding as well as through formation of homo- and heterodimers with other ETS family members, and its activity is tightly controlled by autoinhibitory regions flanking its DNA-binding domain[1][3]. ERG is a critical regulator of endothelial and hematopoietic lineage gene expression and acts via super-enhancer elements that control lineage specificity[4]. Its overexpression or chromosomal rearrangement, particularly TMPRSS2-ERG fusions, are among the most frequent events in prostate cancer[1][2] and also occur in subsets of leukemia and sarcoma[1]. ERG interacts physically and functionally with the androgen receptor (AR) in prostate tissue, modulating AR-dependent gene expression[5]. Its roles in cell differentiation and survival make it a key player both in normal vascular and blood cell development and in the molecular pathogenesis of several malignancies[1][2][4][6]. No clinically established drugs currently target ERG directly, though the TMPRSS2-ERG fusion is used as a biomarker in prostate cancer, and disrupting ERG’s DNA binding or protein-protein interactions is a conceptual mechanism under investigation. Safety concerns for ERG inhibition arise from its essential roles in hematopoietic and endothelial cell maintenance.

Other names

Transcriptional regulator ERGERGerg-3p55Transforming protein ERGv-ets erythroblastosis virus E26 oncogene likeTMPRSS2-ERGTMPRSS2/ERG fusionFUS/ERG fusion proteinETS-related geneLMPHM14v-ets erythroblastosis virus E26 oncogene homologEWS-ERG

(Hypothetical for ERG as a target) – Inhibition of DNA binding, Disruption of protein-protein interactions (e.g., AR/ERG interface), Modulation of transcriptional activity